Mate1 Substrates has 1 known drug interaction based on U.S. FDA drug labeling data. Notable interactions include combinations with Capmatinib. Patients taking Mate1 Substrates should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Moderate
- 1
Moderate (1)
- Mate1 Substrates + Capmatinib— Coadministration may increase MATE1 substrate exposure, which may increase adverse reactions. Decrease substrate dosage …